Recent su icide attempters treated with cognitive therapy were 50 percent less likely to try to k ill themselves again within 18 months than those who did not receive the therapy, report researchers supported by the National Institutes of Health?s (NIH) National Institute of Mental Health (NIMH) and the Center for Disease Control and Prevention (CDC).
Medical device maker Medtronic Inc. said it received approval from European health regulators to sell a heart device that keeps arteries open.
Over half of women who began menopausal hormone therapy because of symptoms such as hot flashes or night sweats experience those symptoms when they discontinue hormone therapy, according to a study in the July 13 issue of JAMA.
A surgical technique that requires the removal, restructure and re-implantation of the nasal septum (the partition of the nose between the nostrils) appears to be a useful option for repairing the hard-to-treat severely deviated septum, according to an article in the July/August issue of the Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.
Eleven patients with Parkinson’s disease (PD) developed pathological gambling behavior following dopamine agonist therapy, a drug therapy to control movement problems caused by Parkinson’s disease, according to a study posted online today which will appear in the September print issue of the Archives of Neurology, one of the JAMA/Archives journals.
A new study indicates there is no specific PSA value that has both high sensitivity and high specificity for monitoring healthy men for prostate cancer, but rather there is a continuum of prostate cancer risk at all values of PSA, according to a study in the July 6 issue of JAMA.
Women who receive fentanyl analgesia during labor may be less likely to breastfeed their infants, according to UK investigators. Based on their findings, they propose that women given this type of analgesia during labor should also receive support to successfully establish breastfeeding in the hospital.
New research suggests that medications commonly referred to as fertility drugs may be ineffective for women who lack a gene called the estrogen receptor beta. The study showed that fertility drugs did not improve ovulation rates in mice that were genetically engineered to lack estrogen receptor beta. The estrogen receptor beta is one of two estrogen receptor proteins which mediate the effects of estrogen hormones and are present throughout the female reproductive tissues. These new data indicate that this receptor plays a critical role in ovulation, and suggests that women who do not have this receptor may benefit more from alternative infertility treatments. The findings are reported in Endocrinology.
A multicenter study of a pill that combines two drugs for hypertension shows significant benefit for people with hard-to-control high blood pressure. The study, conducted at the University of Maryland School of Medicine and 118 other sites, was focused on bringing down systolic blood pressure, the top number in a blood pressure reading, which is the more difficult number to bring down.
Xolair? (omalizumab) add-on therapy significantly reduces attacks in patients with severe allergic asthma. Separate analysis shows first humanised antibody for allergic asthma reduces dependence on steroids to manage attacks.